Jiwon Lee

TL;DR: In this paper, the effectiveness of pharmacological interventions in alleviating dyslipidemia in patients with schizophrenia was evaluated in 48 randomized controlled trials that comprised a total of 3,128 patients.

TL;DR: In this article , the authors examined changes in metabolomic profiles over 12 weeks of antipsychotic treatment to identify metabolites that may associate with AP-induced weight gain, and they also compared baseline metabolomes of participants who gained ≥ 5% baseline body weight to those who gained <5% to identify potential biomarkers of antippsychotic induced weight gain.

TL;DR: The results suggest that mutations in one species can mimic aspects of sex comb patterns in other species, and that there may be a basic “ground plan” in developing tarsal segments that can be rather rapidly shifted in evolution.

TL;DR: These data suggest that the pathobiology of PSDs overlaps and potentially contributes to dysglycemia, and find that metformin may be a potential treatment for early metabolic dysfunction intrinsic to PSDs.